SCHEMBL15380290

SCHEMBL15380290

CC(=O)c1ccc(OCC(O)(Cn2cncn2)c2ccc(F)cc2F)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 15/20 0.67
CYP2C9 P11712 11/20 0.67
CYP2C19 P33261 11/20 0.67
LMNA P02545 2/20 0.67
HSP90AA1 P07900 1/20 0.67
CYP19A1 P11511 1/20 0.67
CYP11B1 P15538 1/20 0.67
CYP11B2 P19099 1/20 0.67
ADRA1A P35348 1/20 0.67
CYP51A1 Q16850 1/20 0.67
HDAC3 O15379 2/20 0.55
HDAC4 P56524 2/20 0.55
HDAC1 Q13547 2/20 0.55
HDAC7 Q8WUI4 2/20 0.55
HDAC2 Q92769 2/20 0.55
HDAC10 Q969S8 2/20 0.55
HDAC11 Q96DB2 2/20 0.55
HDAC8 Q9BY41 2/20 0.55
HDAC6 Q9UBN7 2/20 0.55
HDAC9 Q9UKV0 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14248044 0.91 CYP3A4 (0.65) CYP3A4CYP2C9CYP2C19LMNAHSP90AA1
SCHEMBL17432038 0.88 CYP3A4 (0.61) CYP3A4CYP2C9CYP2C19LMNAHSP90AA1
SCHEMBL14248367 0.88 CYP3A4 (0.64) CYP3A4CYP2C9CYP2C19LMNAHSP90AA1
SCHEMBL15993973 0.87 CYP3A4 (0.57) CYP3A4CYP2C9CYP2C19LMNAHSP90AA1
SCHEMBL15380587 0.86 CYP3A4 (0.61) CYP3A4CYP2C9CYP2C19LMNAHSP90AA1
SCHEMBL14248008 0.86 CYP3A4 (0.61) CYP3A4CYP2C9CYP2C19LMNAHSP90AA1
SCHEMBL15380175 0.86 CYP3A4 (0.70) CYP3A4CYP2C9CYP2C19LMNAHSP90AA1
SCHEMBL17429538 0.86 CYP3A4 (0.58) CYP3A4CYP2C9CYP2C19LMNAHSP90AA1
Fluconazole SCHEMBL6378035 0.85 CYP3A4 (0.88) CYP3A4CYP2C9CYP2C19LMNAHSP90AA1
SCHEMBL20273270 0.84 CYP3A4 (0.54) CYP3A4CYP2C9CYP2C19LMNAHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9512087-B2 Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation COUNCIL FOR SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-12-06 US disclosed
EP-2721014-B1 HYBRID MOLECULES CONTAINING PHARMACOPHORES OF FLUCONAZOLE AS ANTIFUNGAL AGENTS AND THEIR PREPARATION FDC LTD (IN) 2016-10-26 EP disclosed
US-20130303579-A1 HYBRID MOLECULES CONTAINING PHARMACOPHORES OF FLUCONAZOLE AS ANTIFUNGAL AGENTS AND THEIR PREPARATION COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2013-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303579-A1 HYBRID MOLECULES CONTAINING PHARMACOPHORES OF FLUCONAZOLE AS ANTIFUNGAL AGENTS AND THEIR PREPARATION ERG28, CYP51A1, CYP2F1 CYP3A4 27/4885CYP2C9 148/4885CYP2C19 42/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.